New Report Available: Analgesics in Venezuela

Boston, MA -- (SBWIRE) -- 04/23/2014 -- All analgesics categories failed to have positive growth in constant terms. None of them could increase in 2013 over the general inflation rate that reached 27%. Growth in 2013 was lower in constant terms than the CAGR seen over the review period. The main reason behind the unfavourable performance was strict government controls that prohibited price movements in many of the existing brands. This means that firms were unable to increase prices. Nevertheless, production and distribution costs...